Uniphar reportedly in talks to buy out chemist chain
PHARMACY supplies group Uniphar is reportedly in talks to buy chemist chain Sam McCauley group, the Sunday Independent understands.
Investment fund Carlyle Cardinal Ireland (CCI) is the owner of a majority stake in the pharmacy group. It acquired the shareholding in a deal worth in excess of €50m in 2017.
Meanwhile, Irish-listed healthcare group Uniphar,who have it’s Irish headquarters in Citywest, has said it traded in line with expectations during the first six months of the year, while it achieved organic gross profit growth of about five per cent.
The company, which accounts for more than a fifth of the retail pharmacy market in the Republic, is an international business that services the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers.
It recently announced details of an unaudited trading update for the six months ended June 30.
The business performed “in line with the group’s expectations” in terms of both gross profit and earnings before interest, taxes, depreciation and amortisation level (Ebitda), while it also delivered normalised free cash flow conversion “in line with medium-term guidance”.
The company described the performance as “strong” and “demonstrating resilience” in the face of continued macroeconomic uncertainty and inflationary pressures. It continues to maintain “a strong liquidity position”.
